Publication | Open Access
Case Report: Pirfenidone in the Treatment of Post-COVID-19 Pulmonary Fibrosis
29
Citations
17
References
2022
Year
Post-COVID-19 pulmonary fibrosis is a challenging consequence of COVID-19, and our case suggests that pirfenidone may be an effective treatment option.
| Year | Citations | |
|---|---|---|
Page 1
Page 1